Background: In a landscape where both cognitive decline and diabetes are on the ascent globally, an increasingly pertinent question emerges: what interconnections exist between dementia and diabetes in older individuals? Cognitive impairment is a decline in mental abilities that affects memory, attention, reasoning, and other cognitive functions leading to dementia. Diabetes is associated with an increased risk of cognitive impairment and dementia, as well as vascular complications that damage the brain. Several studies have shown that type 2 diabetes and hypertension can impair blood‐brain barrier integrity, cerebral circulation, glucose metabolism, inflammation, oxidative stress, and amyloid‐beta production in the brain. Here, we endeavor to find any correlation between stages of cognitive decline and diabetes in the elderly for better insight and enhanced geriatric care.
Method: In this comparative cross‐sectional study, patients aged 60 years and beyond were recruited from Memory Clinic, Department of Geriatric Medicine, AIIMS, New Delhi. Based on Addenbrooke’s Cognitive Examination‐III (ACE‐III) scoring for cognition, patients with cognitive decline were divided into 3 categories: Subjective Cognitive Impairment (SCI), Mild Cognitive Impairment (MCI) and Major Neurocognitive Disorder (MNCD). 20 patients in each category were taken against 20 controls. Diabetic status was self‐reported and as per their HbA1c levels.
Result: Significant cognitive decline was found in patients with type 2 diabetes with a p‐value of 0.02. As against controls, the association was found highest in MCI group, while SCI had the lowest percentage of diabetics. ACE‐III scores were significantly affected in diabetics. The most affected domain was fluency (p‐value 0.03) followed by memory (p‐value 0.12).
Conclusion: This study shows a clear correlation between cognitive decline and diabetic status in older patients. This work has translational value and clinical utility in the future.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.094719 | DOI Listing |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11713018 | PMC |
ACS Chem Neurosci
January 2025
Department of Bioengineering and Biotechnology, Birla Institute of Technology Mesra, Ranchi, Jharkhand 835215, India.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, extracellular amyloid-β (Aβ) plaque accumulation, and intracellular neurofibrillary tangles. Recent efforts to find effective therapies have increased interest in natural compounds with multifaceted effects on AD pathology. This study explores natural compounds for their potential to mitigate AD pathology using molecular docking, ADME screening, and assays, with ruscogenin─a steroidal sapogenin from emerging as a promising candidate.
View Article and Find Full Text PDFTraffic Inj Prev
January 2025
National Key Laboratory of Human Factors Engineering, China Astronaut Research and Training Centre, Beijing, China.
Objective: Attention forms the foundation for the formation of situation awareness. Low situation awareness can lead to driving performance decline, which can be dangerous in driving. The goal of this study is to investigate how different types of pre-takeover tasks, involving cognitive, visual and physical resources engagement, as well as individual attentional function, affect driver's attention restoration in conditionally automated driving.
View Article and Find Full Text PDFMedicine (Baltimore)
January 2025
Department of Anesthesiology, Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, China.
Background: This study compares the outcomes of general anesthesia (GA) and regional anesthesia (RA) in geriatric hip fracture surgery to determine optimal anesthesia strategies for this population.
Methods: A comprehensive literature review was conducted, analyzing studies comparing GA and RA in elderly patients undergoing hip fracture surgery. Studies encompassed various designs, including randomized controlled trials, cohort studies, and meta-analyses.
Exp Physiol
January 2025
Department of Physiology, School of Medicine, University College Cork, Cork, Ireland.
Absence of the structural protein, dystrophin, results in the neuromuscular disorder Duchenne Muscular Dystrophy (DMD). In addition to progressive skeletal muscle dysfunction, this multisystemic disorder can also result in cognitive deficits and behavioural changes that are likely to be consequences of dystrophin loss from central neurons and astrocytes. Dystrophin-deficient mdx mice exhibit decreases in grey matter volume in the hippocampus, the brain region that encodes and consolidates memories, and this is exacerbated with ageing.
View Article and Find Full Text PDFAm J Ther
January 2025
Faculty of Medicine, "Transilvania" University, Brasov, Romania; and.
Background: Dementia leads to cognitive decline affecting memory, thinking, and behavior. Current pharmaceutical treatments are symptomatic, with limited efficacy and significant drawbacks. Ginkgo biloba extract (EGb761) is being explored as an adjuvant therapy for dementia because of its potential neuroprotective effects.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!